A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

NCT07214870 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Fatty Liver Disease

Interventions

DRUG: NNC4005-001
DRUG: Placebo

Sponsor

Novo Nordisk A/S